drugset / Trial / NCT00634569
Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center, open-label study to assess the efficacy and safety of Flebogamma 5% DIF in the pediatric population.
Timeline
- Start
- 2008-05
- Primary completion
- 2011-03
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | — | Intravenous |